Strong FGFR3 staining is a marker for FGFR3 fusions and poor prognosis in diffuse gliomas

被引：0
|
作者：
Granberg, Kirsi J.
Annala, Matti
Lehtinen, Birgitta
Kesseli, Juha
Haapasalo, Joonas
Yli-Harja, Olli
Visakorpi, Tapio
Haapasalo, Hannu
Nykter, Matti
Zhang, Wei
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-5011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5011
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Clinico-pathological and epigenetic heterogeneity of diffuse gliomas with FGFR3::TACC3 fusion
    Alice Métais
    Arnault Tauziède-Espariat
    Jeremy Garcia
    Romain Appay
    Emmanuelle Uro-Coste
    David Meyronet
    Claude-Alain Maurage
    Fanny Vandenbos
    Valérie Rigau
    Dan Christian Chiforeanu
    Johan Pallud
    Suhan Senova
    Raphaël Saffroy
    Carole Colin
    Myriam Edjlali
    Pascale Varlet
    Dominique Figarella-Branger
    Acta Neuropathologica Communications, 11
  • [22] The Histologic and Molecular Features of Pediatric and Adult Gliomas with Alterations in FGFR1 and FGFR3
    Bale, Tejus A.
    Alexandrescu, Sanda
    Manam, Monica
    Lindeman, Neal I.
    Dubuc, Adrian
    Ligon, Azra H.
    Ligon, Keith L.
    LABORATORY INVESTIGATION, 2017, 97 : 429A - 429A
  • [23] Study of FGFR3 Expression and FGFR3 Mutations in Molecular Subtypes of Muscle Invasive Bladder Cancer
    Kaushal, Seema
    Roy, Charli
    Seth, Amlesh
    Sahoo, Ranjit
    Batra, Atul
    Dinda, Amit
    LABORATORY INVESTIGATION, 2024, 104 (03) : S966 - S967
  • [24] Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer
    Andrew J. Weickhardt
    David K. Lau
    Margeaux Hodgson-Garms
    Austen Lavis
    Laura J. Jenkins
    Natalia Vukelic
    Paul Ioannidis
    Ian Y. Luk
    John M. Mariadason
    BMC Cancer, 22
  • [25] Detection of FGFR3 mutations and fusions in bladder cancer samples: Comparison of the MODAPLEX FGFR panel with therascreen FGFR Kit
    Weissbach, R.
    Wirtz, R. M.
    Weber, A.
    Schubert, T.
    Waldner, M.
    Veltrup, E.
    Hake, R.
    Eidt, S.
    Graff, J.
    Grunwald, V.
    Ecke, T.
    VIRCHOWS ARCHIV, 2024, 485 : S137 - S137
  • [26] The Histologic and Molecular Features of Pediatric and Adult Gliomas with Alterations in FGFR1 and FGFR3
    Bale, Tejus A.
    Alexandrescu, Sanda
    Manam, Monica
    Lindeman, Neal I.
    Dubuc, Adrian
    Ligon, Azra H.
    Ligon, Keith L.
    MODERN PATHOLOGY, 2017, 30 : 429A - 429A
  • [27] Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer
    Weickhardt, Andrew J.
    Lau, David K.
    Hodgson-Garms, Margeaux
    Lavis, Austen
    Jenkins, Laura J.
    Vukelic, Natalia
    Ioannidis, Paul
    Luk, Ian Y.
    Mariadason, John M.
    BMC CANCER, 2022, 22 (01)
  • [28] Dimerization of FGFR3 in Living Cells
    Singh, Deo R.
    King, Chris
    Placone, Jesse
    Cao, Qingqing
    Ghosh, Praveen
    Hristova, Kalina
    BIOPHYSICAL JOURNAL, 2014, 106 (02) : 480A - 480A
  • [29] FGFR3 overexpression in multiple myeloma
    Chang, H
    Yi, QL
    Trudel, S
    Stewart, AK
    LABORATORY INVESTIGATION, 2005, 85 : 224A - 224A
  • [30] FGFR3 autoantibodies in sensory neuronopathy
    Latov, Norman
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2020, 91 (01): : 8 - 8
12345